InMed is proud to take part in the upcoming Fierce Biotech webinar “Alzheimer’s Outlook – Neuroinflammation, the Next Step.”
InMed’s Senior VP, Preclinical Research and Development, Dr. Eric Hsu, will join a panel of experts to speak about recent breakthroughs in Alzheimer’s disease research and the effects of neuroinflammation in disease progression. Details are as follows:
Alzheimer’s Outlook – Neuroinflammation, the Next Step
Date: November 12, 2024
Time: 2:00pm ET
Now available on demand: https://www.fiercebiotech.com/premium/webinar/breakthroughs-alzheimers-research-and-drug-development
In this webinar, we’ll hear about:
- the latest research into the causes of Alzheimer’s disease
- the different therapeutic pathways being explored
- drugs in development and their pharmacological targets
- the pathophysiological effects of neuroinflammation in Alzheimer’s disease
If you are a neurodegenerative disease researcher or clinician or study brain health or are a caregiver for someone living with Alzheimer’s disease, join this webinar to learn what the future holds in Alzheimer’s disease therapeutic development.
Speakers for this event:
- Phyllis Ferrell, DrPH, MBA (Moderator), Chief Impact Officer at StartUp Health’s Alzheimer’s Moonshot
- David Morgan, PhD, Director of the Alzheimer’s Alliance and MSU Foundation Professor of Translational Neuroscience at Michigan State University
- Marwan Sabbagh, MD, Moreno Family Chair for Alzheimer’s Research and Vice Chairman for Research and Professor of Neurology at the Barrow Neurological Institute in Phoenix Arizona
- Barry Greenberg, PhD, Associate Professor in the Department of Neurology and Director of Alzheimer’s Disease Translational Center at the Johns Hopkins University School of Medicine
- Eric Hsu, PhD, Senior Vice President of Preclinical Research and Development at InMed Pharmaceuticals